Patent expiry and biosimilars: difference between revisions
Diff·revision 3 → 4·14:27, 5 Jan 2025
Difference between revision 3 and revision 4 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 3 — 14:17, 25 Dec 2024 MoveRequestMio (talk) correct the description of the shortage-list mechanism 1,842 bytes ±0 | Revision 4 — 14:27, 5 Jan 2025 ShortageShona (talk) add short description 1,842 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |